Flap endonuclease 1 is overexpressed in prostate cancer and is associated with a high Gleason score

被引：91

作者：

Lam, John S.

Seligson, David B.

Yu, Hong

Li, Ai

Eeva, Mervi

Pantuck, Allan J.

Zeng, Gang

Horvath, Steve

Belldegrun, Arie S.

机构：

[1] Univ Calif Los Angeles, David Geffen Sch Med, Dept Urol, Los Angeles, CA USA

[2] Univ Calif Los Angeles, David Geffen Sch Med, Dept Pathol & Lab Med, Los Angeles, CA USA

[3] Univ Calif Los Angeles, David Geffen Sch Med, Dept Biostat, Los Angeles, CA USA

[4] Univ Calif Los Angeles, David Geffen Sch Med, Dept Human Genet, Los Angeles, CA USA

来源：

BJU INTERNATIONAL | 2006年 / 98卷 / 02期

关键词：

flap endonuclease 1; Gleason grade; prostate cancer; tissue microarray; tumour markers; EUKARYOTIC DNA-REPLICATION; CELL NUCLEAR ANTIGEN; GENE FEN1; EXPRESSION; IDENTIFICATION; OPTIMIZATION; MITOXANTRONE; EXONUCLEASE; MICROARRAYS; PREDNISONE;

D O I：

10.1111/j.1464-410X.2006.06224.x

中图分类号：

R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];

学科分类号：

1002 ; 100201 ;

摘要：

To investigate the expression and potential clinical usefulness of structure-specific flap endonuclease 1 (FEN-1) in human primary prostate cancer using tissue microarray technology, as FEN-1 was recently identified to be overexpressed in CL1.1, the most aggressive clone generated from the hormone-refractory prostate cancer cell line CL1.

引用

页码：445 / 451

页数：7

共 50 条

[31] Gene expression signature of Gleason score is associated with prostate cancer outcomes in a radical prostatectomy cohort
Jhun, Min A.
Geybels, Milan S.
Wright, Jonathan L.
Kolb, Suzanne
April, Craig
Bibikova, Marina
Ostrander, Elaine A.
Fan, Jian-Bing
Feng, Ziding
Stanford, Janet L.
CANCER RESEARCH, 2017, 77
[32] The use of autoantibody signatures for the prediction of prostate cancer Gleason score
Bradford, TJ
Wang, XJ
Wang, R
Yu, JJ
Ghosh, D
Wei, JT
Chinnaiyan, AM
JOURNAL OF UROLOGY, 2006, 175 (04): : 274 - 274
[33] Gene expression signature of Gleason score is associated with prostate cancer outcomes in a radical prostatectomy cohort
Jhun, Min A.
Geybels, Milan S.
Wright, Jonathan L.
Kolb, Suzanne
April, Craig
Bibikova, Marina
Ostrander, Elaine A.
Fan, Jian-Bing
Feng, Ziding
Stanford, Janet L.
ONCOTARGET, 2017, 8 (26) : 43035 - 43047
[34] Multimodal Radiomic Features for the Predicting Gleason Score of Prostate Cancer
Chaddad, Ahmad
Kucharczyk, Michael J.
Niazi, Tamim
CANCERS, 2018, 10 (08)
[35] Metabolomics of Prostate Cancer Gleason Score in Tumor Tissue and Serum
Penney, Kathryn L.
Tyekucheva, Svitlana
Rosenthal, Jacob
El Fandy, Habiba
Carelli, Ryan
Borgstein, Stephanie
Zadra, Giorgia
Fanelli, Giuseppe Nicolo
Stefanizzi, Lavinia
Giunchi, Francesca
Pomerantz, Mark
Peisch, Samuel
Coulson, Hannah
Lis, Rosina
Kibel, Adam S.
Fiorentino, Michelangelo
Umeton, Renato
Loda, Massimo
MOLECULAR CANCER RESEARCH, 2021, 19 (03) : 475 - 484
[36] Impact of reporting rules of biopsy Gleason score for prostate cancer
Kuroiwa, K.
Uchino, H.
Yokomizo, A.
Naito, S.
JOURNAL OF CLINICAL PATHOLOGY, 2009, 62 (03) : 260 - 263
[37] Gleason Score 6-Prostate Cancer or Benign Variant?
Knuechel, Ruth
ONCOLOGY RESEARCH AND TREATMENT, 2015, 38 (12) : 629 - 632
[38] Expression signatures that correlated with Gleason score and relapse in prostate cancer
Bibikova, Marina
Chudin, Eugene
Arsanjani, Amir
Zhou, Lixin
Garcia, Eliza Wickham
Modder, Joshua
Kostelec, Monica
Barker, David
Downs, Tracy
Fan, Jian-Bing
Wang-Rodriguez, Jessica
GENOMICS, 2007, 89 (06) : 666 - 672
[39] Diagnostic Gleason score and castration-resistant prostate cancer
Jayaram, A.
Attard, G.
ANNALS OF ONCOLOGY, 2016, 27 (06) : 962 - 964
[40] Deep Radiomic Analysis to Predict Gleason Score in Prostate Cancer
Chaddad, Ahmad
Kucharczyk, Michael J.
Desrosiers, Christian
Okuwobi, Idowu Paul
Katib, Yousef
Zhang, Mingli
Rathore, Saima
Sargos, Paul
Niazi, Tamim
IEEE ACCESS, 2020, 8 : 167767 - 167778

← 1 2 3 4 5 →